GRST — Ethema Health Cashflow Statement
0.000.00%
Last trade - 00:00- $3.09m
- $9.88m
- $6.02m
- 42
- 67
- 17
- 36
Annual cashflow statement for Ethema Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.08 | -1.57 | 0.295 | 1.01 | -2.17 |
| Depreciation | |||||
| Non-Cash Items | -3.75 | 1.18 | 0.525 | -2.11 | 0.416 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.44 | -0.141 | -0.044 | -0.104 | 0.68 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -0.102 | -0.086 | 1.58 | -0.53 | -0.456 |
| Capital Expenditures | — | -0.133 | -0.316 | -5.25 | -0.06 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.684 | -0.44 | -0.396 | 7.7 | -0.948 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.684 | -0.573 | -0.712 | 2.45 | -1.01 |
| Financing Cash Flow Items | — | — | 0.352 | -0.414 | 0.29 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.854 | 0.59 | 0.304 | -2.08 | 1.68 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.088 | -0.042 | 0.092 | -0.072 | 0.176 |